Consumer-price growth will hit the European Central Bank’s 2% target by the end of 2025, according to Governing Council member Boris Vujcic. "We expect inflation to continue to fall, and in some ...

Croatian public broadcaster HRT1 has extended its remake of Skam following a stellar first series, Broadcast International has learned. The show, sold via German distributor Beta Film, is known ...

The European Central Bank will go on lowering borrowing costs in 2025, according to Governing Council member Boris Vujcic. “The direction is clear, it’s the continuation of the direction from 2024, ...

ZAGREB: Skam, the groundbreaking format from Norway's NRK, is getting a new adaptation in Croatia, titled Sram and produced by CGM Films for the Croatian Radiotelevision (HRT). The series is set to be ...

TV Drama is exclusively devoted to the business of international drama series and specials. It is produced by the same team behind World Screen, the leading source of information for the international ...

THE European Central Bank (ECB) is done with interest-rate increases for the time being, Governing Council member Boris Vujcic said. “We have finished with the process of raising interest rates for ...

Please provide your email address to receive an email when new articles are posted on . Intravaginal ring that contains estradiol and progesterone reduced vaginal pH and percentage of parabasal cells.

DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience ...

This was a randomized, open-label, 2-arm, parallel group study in 21 healthy postmenopausal women with an intact uterus. Women were randomized (1:1) to either DARE-HRT1 IVR1 (E2 80 μg/d with P4 4 mg/d ...

DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy SAN DIEGO, April 18, 2023 (GLOBE NEWSWIRE) -- Daré ...

The company prioritizes unmet needs for women in contraception, fertility, and vaginal and sexual health. Sabrina Martucci Johnson never planned on being a founder and CEO of a women’s healthcare ...

Daré Bioscience, Inc. today announced topline PK results from its Phase 1 / 2 clinical trial of DARE-HRT1 that support the potential of DARE-HRT1 as an effective hormone therapy (HT) based on the ...